With all four core TRIUMPH trials now complete TRIUMPH-4 (December 2025, 28.7% weight loss), TRIUMPH-1 (May 2026, 28.3% in 2,339 patients), TRIUMPH-2 (July 2026, obesity + diabetes), and TRIUMPH-3 (July 2026, obesity + cardiovascular disease) plus TRANSCEND-T2D-1 (June 2026, the first diabetes-specific Phase 3 readout), this investigational medication now has the full data package Eli Lilly says it needs for regulatory submission
A Whoosh physician will review your full health history, lab work, and treatment goals before recommending a protocol
GLP-1 medications are compatible with most postpartum medications, including common antidepressants, thyroid medications, and prenatal vitamins
These injections offer various advantages, such as assisting in weight loss, enhancing energy levels, promoting hair and nail growth, and much more
Timing does not eliminate side effects, but evening dosing isolates nausea and flushing to sleep hours when they are least disruptive